protriptyline structure
|
Common Name | protriptyline | ||
|---|---|---|---|---|
| CAS Number | 438-60-8 | Molecular Weight | 263.37700 | |
| Density | 1.026 g/cm3 | Boiling Point | 407.7ºC at 760 mmHg | |
| Molecular Formula | C19H21N | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 198.3ºC | |
Use of protriptylineProtriptyline is a potent antidepressant agent. Protriptyline inhibits AChE activity with IC50 value of 0.06 mM and inhibits Aβ Self-Assembly. Protriptyline can be used for depression and Alzheimers disease[1][2][3]. |
| Name | protriptyline |
|---|---|
| Synonym | More Synonyms |
| Description | Protriptyline is a potent antidepressant agent. Protriptyline inhibits AChE activity with IC50 value of 0.06 mM and inhibits Aβ Self-Assembly. Protriptyline can be used for depression and Alzheimers disease[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | Protriptyline (0-70 μM; 24 hours; PC3 cells) causes cytotoxicity in PC3 cells[2]. Cell Cytotoxicity Assay[2] Cell Line: PC3 cells Concentration: 50, 60 and 70 μM Incubation Time: 24 hours Result: Decreased cell viability in a concentration-dependent manner. |
| In Vivo | Protriptyline (10 mg/kg; i.p.; for 21 days; rat model of AD) improves spatial learning and retention memory in STZ treated rats[3]. Animal Model: Rat model of AD[3] Dosage: 10 mg/kg Administration: Intraperitoneal injection; for 21 days. Result: Reduced pTau, Aβ42 and BACE-1 levels, neurodegeneration, oxidative stress and glial activation. Improved p-ERK/ERK ratio and enhanced BDNF and CREB levels by reducing NFκB and GFAP expression. |
| References |
| Density | 1.026 g/cm3 |
|---|---|
| Boiling Point | 407.7ºC at 760 mmHg |
| Molecular Formula | C19H21N |
| Molecular Weight | 263.37700 |
| Flash Point | 198.3ºC |
| Exact Mass | 263.16700 |
| PSA | 12.03000 |
| LogP | 4.69280 |
| InChIKey | BWPIARFWQZKAIA-UHFFFAOYSA-N |
| SMILES | CNCCCC1c2ccccc2C=Cc2ccccc21 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2921499090 |
|---|
|
~%
protriptyline CAS#:438-60-8 |
| Literature: Apicore, LLC Patent: US2008/139848 A1, 2008 ; Location in patent: Page/Page column 3 ; |
|
~%
protriptyline CAS#:438-60-8 |
| Literature: Engelhardt,E.L. et al. Journal of Medicinal Chemistry, 1968 , vol. 11, # 2 p. 325 - 332 |
|
~%
protriptyline CAS#:438-60-8 |
| Literature: Gribble,G.W. et al. Synthesis, 1977 , p. 172 - 176 |
|
~%
protriptyline CAS#:438-60-8 |
| Literature: Engelhardt,E.L. et al. Journal of Medicinal Chemistry, 1968 , vol. 11, # 2 p. 325 - 332 |
| HS Code | 2921499090 |
|---|---|
| Summary | 2921499090 other aromatic monoamines and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
| N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine |
| 5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene |
| DIBENZO(A,D)CYCLOHEPTENE-5-PROPYLAMINE,N-METHYL |
| Amimetilina |
| 5H-Dibenzo[a,d]cycloheptene-5-propylamine,N-methyl |
| Triptil |
| N-methyl-5H-dibenzo(a,d)cycloheptene-5-propanamine |
| Protriptylin |
| Protryptyline |
| 3-(dibenzo(a,d)cyclohepten-5-yl)propylmethylamine |
| proptriptyline |
| Vivactil |
| PROTRIPTYLINE |